Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Globus Medical, Inc. before investing.

In this article, we go over a few key elements for understanding Globus Medical, Inc.’s stock price such as:

• Globus Medical, Inc.’s current stock price and volume
• Why Globus Medical, Inc.’s stock price changed recently
• Upgrades and downgrades for GMED from analysts
• GMED’s stock price momentum as measured by its relative strength

About Globus Medical, Inc. (GMED)

Before we jump into Globus Medical, Inc.’s stock price, history, target price and what caused it to recently dip, let’s take a look at some background.

Globus Medical, Inc. develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products comprising traditional fusion implants, such as pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices; treatment options for motion preservation technologies consisting of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional solutions to treat vertebral compression fractures; and biologic solutions, such as allografts and synthetic alternatives. It also provides orthopedic trauma solutions, including limb reconstruction, fracture plating, intramedullary nailing, external fixation, and compression screw technologies; hip and knee arthroplasty solutions, including modular cement and cementless hip stems, acetabular cups, femoral heads, highly cross-linked liners, partial knee systems, cruciate retaining, posterior stabilized, and revision options; spinal cord stimulation services; and neuromonitoring services, which provide onsite and remote monitoring of the neurological systems. In addition, the company offers ExcelsiusGPS platform, a robotic guidance and navigation system for minimally invasive and open procedures; Surgimap, a surgical planning software platform; Excelsius3D, a platform combined with ExcelsiusGPS that provides an intraoperative and image-guided robotic navigation solution; ExcelsiusHub, which provides real-time patient array monitoring, tissue sparing drills, and registration flexibility; and ExcelsiusFlex, a total knee arthroplasty robotic solution. Further, it distributes human cells, tissues, and cellular and tissue-based products. The company sells its products through direct and distributor sales representatives; and independent sales agents. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.

Want to learn more about Globus Medical, Inc.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Globus Medical, Inc..

Globus Medical, Inc.’s Stock Price as of Market Close

As of July 31, 2026, 4:00 PM, CST, Globus Medical, Inc.’s stock price was $78.790.

Globus Medical, Inc. is down 1.83% from its previous closing price of $80.260.

During the last market session, Globus Medical, Inc.’s stock traded between $77.143 and $79.580. Currently, there are approximately 135.36 million shares outstanding for Globus Medical, Inc..

Globus Medical, Inc.’s price-earnings (P/E) ratio is currently at 18.4, which is low compared to the Health Care Equipment & Supplies industry median of 31.1. The price-earnings ratio gauges market expectation of future performance by relating a stock’s current share price to its earnings per share.

Globus Medical, Inc. Stock Price History

Globus Medical, Inc.’s (GMED) price is currently down 0.28% so far this month.

During the month of July, Globus Medical, Inc.’s stock price has reached a high of $82.040 and a low of $74.385.

Over the last year, Globus Medical, Inc. has hit prices as high as $101.398 and as low as $51.790. Year to date, Globus Medical, Inc.’s stock is down 9.76%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Globus Medical, Inc. Stock’s Price to Dip?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

One of the most common factors that can drastically impact a stock’s price is analyst upgrades and downgrades. When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. However, as of July 31, 2026,, no analysts have changed their rating of Globus Medical, Inc.’s stock over the last month.

Additionally, you'll want to evaluate Globus Medical, Inc.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Globus Medical, Inc.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Globus Medical, Inc.’s current valuation based on AAII’s Value Grade is a C, which means it is considered to be Average.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Globus Medical, Inc. (GMED) by visiting AAII Stock Evaluator.

Relative Price Strength of Globus Medical, Inc.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of July 31, 2026, Globus Medical, Inc. has a weighted four-quarter relative price strength of 3.42%, which translates to a Momentum Score of 65 and is considered to be Strong.

Want to learn more about how Globus Medical, Inc. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Globus Medical, Inc. Stock Price: Bottom Line

As of July 31, 2026, Globus Medical, Inc.’s stock price is $78.790, which is down 1.83% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Globus Medical, Inc. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.